FDA Warning Letter — AriBio H&B
The FDA took a Warning Letter action against AriBio H&B on Oct 8, 2021 (Jecheon, South Korea). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- AriBio H&B
- Date
- Oct 8, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Jecheon (South Korea)